ICD-10 Coding for Benzo Use Disorder(F13.1, F13.10, F13.10A)
Explore detailed ICD-10 coding guidelines for benzodiazepine use disorder, including documentation requirements and common coding pitfalls.
Complete code families applicable to Benzo Use Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F13.10 | Sedative, hypnotic or anxiolytic abuse, uncomplicated | Use when the patient exhibits mild abuse without dependence. |
|
| F13.20 | Sedative, hypnotic or anxiolytic dependence, uncomplicated | Use when the patient exhibits dependence with or without withdrawal symptoms. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBenzo Use Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Benzo Use Disorder.
Failure to document withdrawal symptoms when present
Impact
Clinical: May lead to inadequate treatment planning., Regulatory: Increases risk of audit due to incomplete documentation., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Use structured templates, Regularly review documentation guidelines
Using unspecified codes like F13.90 when specific criteria are documented
Impact
Reimbursement: May result in lower reimbursement rates., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces accuracy of patient records.
Mitigation
Query the provider for specific criteria to use the correct code.
Specificity of Coding
Impact
Using unspecified codes when specific criteria are documented.
Mitigation
Ensure all DSM-5 criteria and symptoms are documented to support specific coding.